Ginsana

Ginsana is a Swiss pharmaceutical company specializing in the research, development, and manufacturing of high-quality natural health products and phytopharmaceuticals. Based in Bioggio, the company is globally recognized for its standardized Panax ginseng extract, G115, which has been featured in numerous clinical trials. In 2013, Ginsana was acquired by SFI Health, and it currently serves as the group's primary manufacturing and R&D hub. The company's portfolio includes evidence-based brands such as Gincosan and Songha Night, which target cognitive health, immunity, and sleep. Ginsana operates under strict GMP standards and provides contract manufacturing services for the global healthcare market. Its focus remains on bridging the gap between traditional herbal medicine and modern pharmaceutical science.